Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Neuropathology and Applied Neurobiology
|
April 29, 2024
Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome
Allison R Hanaford, Asheema Khanna, Katerina James, et al.
Circulation Research
|
February 12, 2011
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
Dao-Fu Dai, Simon C Johnson, Jason J Villarin, et al.
Kidney International
|
November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
Simon C Johnson, Frank Martinez, Alessandro Bitto, et al.
Frontiers in Genetics
|
August 11, 2015
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
Simon C Johnson, Melana E Yanos, Alessandro Bitto, et al.
Science (New York, N.Y.)
|
November 16, 2013
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome
Simon C Johnson, Melana E Yanos, Ernst-Bernhard Kayser, et al.
International Journal of Cancer
|
August 10, 2013
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma
Jocelyn H Wright, Melissa M Johnson, Masami Shimizu-Albergine, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
<i>MyD88</i> deficiency modestly attenuates disease in a Leigh syndrome mouse model while enrofloxacin accelerates disease
Allison R Hanaford, Elizaveta A Olkhova, Ryan Liao, et al.
Plos One
|
March 29, 2019
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
Amanda H Kahn-Kirby, Akiko Amagata, Celine I Maeder, et al.
Nature
|
April 5, 2019
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Nature
|
June 15, 2018
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Neuropathology and Applied Neurobiology
|
April 29, 2024
Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome
Allison R Hanaford, Asheema Khanna, Katerina James, et al.
Circulation Research
|
February 12, 2011
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
Dao-Fu Dai, Simon C Johnson, Jason J Villarin, et al.
Kidney International
|
November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
Simon C Johnson, Frank Martinez, Alessandro Bitto, et al.
Frontiers in Genetics
|
August 11, 2015
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
Simon C Johnson, Melana E Yanos, Alessandro Bitto, et al.
Science (New York, N.Y.)
|
November 16, 2013
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome
Simon C Johnson, Melana E Yanos, Ernst-Bernhard Kayser, et al.
International Journal of Cancer
|
August 10, 2013
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma
Jocelyn H Wright, Melissa M Johnson, Masami Shimizu-Albergine, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
<i>MyD88</i> deficiency modestly attenuates disease in a Leigh syndrome mouse model while enrofloxacin accelerates disease
Allison R Hanaford, Elizaveta A Olkhova, Ryan Liao, et al.
Plos One
|
March 29, 2019
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
Amanda H Kahn-Kirby, Akiko Amagata, Celine I Maeder, et al.
Nature
|
April 5, 2019
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Nature
|
June 15, 2018
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, et al.
Page
of 5